معرفی
Dora Hammerl is a Researcher at Erasmus MC in the Department of Radiotherapy, actively contributing to cancer immunology and immunotherapy research. Her work is highly collaborative, involving key researchers in oncology and immunology, and is focused on advancing T cell-based treatments for triple-negative breast cancer.
Her research interests include T cell engineering, epitope-specific immune responses, tumor microenvironment dynamics, and adoptive immunotherapy. She applies both experimental and computational methods to understand and enhance anti-tumor immunity, with a particular focus on TCR-modified T cells and immune cell spatial organization in tumors.
Analysis of her recent publications reveals a strong trend in developing and evaluating novel immunotherapies, particularly TCR-engineered T cells targeting cancer germline antigens, and creating tools for immune contexture analysis in breast cancer. Her work bridges molecular immunology with clinical oncology, aiming to improve survival prediction and therapeutic efficacy.
Dora Hammerl has supervised at least one doctoral student and is involved in significant collaborative research projects. Her publications in high-impact journals such as Cancer Discovery and npj Imaging reflect her active role in cutting-edge cancer research and grant-supported science, although specific grant details are not provided.
She is part of a research team that developed TME-analyzer, an interactive image analysis tool for studying immune cell interactions in the tumor microenvironment, indicating her involvement in both wet-lab and computational approaches within a multidisciplinary research group.
